http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100666420-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E04H15-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E04H15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E04H15-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 2005-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100666420-B1 |
| titleOfInvention | Pharmaceutical composition for improving or treating atopic dermatitis containing snakeberry extract as an active ingredient |
| abstract | The present invention relates to a pharmaceutical composition for improving or treating atopic dermatitis, which comprises the extract of Duchesnea chrysantha and its active ingredient, and more specifically, the extract of the snakeberry extracted with water, ethanol or methanol as an extraction solvent and the active ingredient It relates to atopic dermatitis improvement or treatment containing a pharmaceutical composition. Pharmaceutical composition containing the snakeberry extract of the present invention as an active ingredient, itching improvement, erythema improvement, epidermal regeneration, antimicrobial action of atopic dermatitis through immunosuppressive ability, inhibition of nitric oxide (NO) production, cytokine (cytokine) secretion control, etc. It can be effectively used for atopic dermatitis improvement and treatment because it can effectively improve or treat atopic symptoms by showing skin soothing effect. |
| priorityDate | 2004-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 183.